| [1] |
Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(4): 284-296. DOI: 10.3322/caac.21456.
|
| [2] |
Cabasag CJ, Arnold M, Rutherford M, et al. Shifting incidence and survival of epithelial ovarian cancer (1995-2014): a SurvMark-2 study[J]. Int J Cancer, 2023, 152(9): 1763-1777. DOI: 10.1002/ijc.34403.
|
| [3] |
Csorba R, Buderath P, Ingenwerth M, et al. Isolated abdominal wall metastasis 42 years after curative surgery for ovarian cancer: a case report[J]. Case Rep Womens Health, 2025, 45: e00696. DOI: 10.1016/j.crwh.2025.e00696.
|
| [4] |
Han L, Liu W, Shi G, et al. The minimally invasive resection of port-site metastasis of ovarian cancer after laparoscopy with cutaneous integrity: a case report and literature review[J]. BMC Womens Health, 2024, 24(1): 494. DOI: 10.1186/s12905-024-03353-z.
pmid: 39242540
|
| [5] |
Mahdi H, Wiechert A, Lockhart D, et al. Impact of age on 30-day mortality and morbidity in patients undergoing surgery for ovarian cancer[J]. Int J Gynecol Cancer, 2015, 25(7): 1216-1223. DOI: 10.1097/IGC.0000000000000486.
pmid: 26076218
|
| [6] |
van Walree IC, van Soolingen NJ, Hamaker ME, et al. Treatment decision-making in elderly women with ovarian cancer: an age-based comparison[J]. Int J Gynecol Cancer, 2019, 29(1): 158-165. DOI: 10.1136/ijgc-2018-000026.
pmid: 30640699
|
| [7] |
俞洋丽, 郝志敏. 老年上皮性卵巢癌患者早期死亡预测模型的构建与验证[J]. 现代妇产科进展, 2023, 32(7): 522-528. DOI: 10.13283/j.cnki.xdfckjz.2023.07.031.
|
| [8] |
Falandry C, Savoye AM, Stefani L, et al. EWOC-1: a randomized trial to evaluate the feasibility of three different first-line chemotherapy regimens for vulnerable elderly women with ovarian cancer (OC): a GCIG-ENGOT-GINECO study[J]. J Clin Oncol, 2019, 37(15_suppl): 5508-5508. DOI: 10.1200/jco.2019.37.15_suppl.5508.
|
| [9] |
Ataseven B, du Bois A, Harter P, et al. Impact of abdominal wall metastases on prognosis in epithelial ovarian cancer[J]. Int J Gynecol Cancer, 2016, 26(9): 1594-1600. DOI: 10.1097/IGC.0000000000000826.
pmid: 27654263
|
| [10] |
Cai Y, Shu T, Zheng H. Disparities in treatment modalities and survival among older patients with high-grade serous ovarian cancer[J]. BMC Womens Health, 2024, 24(1): 100. DOI: 10.1186/s12905-024-02938-y.
pmid: 38326784
|
| [11] |
王小伟, 申娅辉, 胡丽娟, 等. 老年卵巢癌患者临床特征及预后分析[J]. 肿瘤预防与治疗, 2024, 37(5): 405-412. DOI: 10.3969/j.issn.1674-0904.2024.05.006.
|
| [12] |
Lin YH, Wu CH, Fu HC, et al. Prognostic significance of elevated pretreatment serum levels of CEA and CA-125 in epithelial ovarian cancer[J]. Cancer Biomark, 2020, 28(3): 285-292. DOI: 10.3233/CBM-201455.
|
)
